252 related articles for article (PubMed ID: 37650539)
21. Critical considerations for targeting colorectal liver metastases with nanotechnology.
Arshad U; Sutton PA; Ashford MB; Treacher KE; Liptrott NJ; Rannard SP; Goldring CE; Owen A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1588. PubMed ID: 31566913
[TBL] [Abstract][Full Text] [Related]
22. Nanomedical engineering: shaping future nanomedicines.
Luo D; Carter KA; Lovell JF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
[TBL] [Abstract][Full Text] [Related]
23. Biological rationale for the design of polymeric anti-cancer nanomedicines.
Zhou Y; Kopeček J
J Drug Target; 2013 Jan; 21(1):1-26. PubMed ID: 23009337
[TBL] [Abstract][Full Text] [Related]
24. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
Wang Y; Cai R; Chen C
Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
[TBL] [Abstract][Full Text] [Related]
25. Organoids technology for advancing the clinical translation of cancer nanomedicine.
Zhao DK; Liang J; Huang XY; Shen S; Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
[TBL] [Abstract][Full Text] [Related]
26. Nanomedicines: Redefining traditional medicine.
Lu W; Yao J; Zhu X; Qi Y
Biomed Pharmacother; 2021 Feb; 134():111103. PubMed ID: 33338747
[TBL] [Abstract][Full Text] [Related]
27. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.
Sun D; Zhou S; Gao W
ACS Nano; 2020 Oct; 14(10):12281-12290. PubMed ID: 33021091
[TBL] [Abstract][Full Text] [Related]
28. Recent Progress and Challenges in Clinical Translation of Nanomedicines in Diagnosis and Treatment of Lung Cancer.
Yadav B; Chauhan M; Singh RP; Sonali ; Shekhar S
Curr Drug Targets; 2024; 25(1):12-24. PubMed ID: 38058096
[TBL] [Abstract][Full Text] [Related]
29. Next-Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions.
Fletcher NL; Kempe K; Thurecht KJ
Macromol Rapid Commun; 2020 Sep; 41(18):e2000319. PubMed ID: 32767396
[TBL] [Abstract][Full Text] [Related]
30. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches.
Jäger E; Giacomelli FC
Curr Top Med Chem; 2015; 15(4):328-44. PubMed ID: 25633209
[TBL] [Abstract][Full Text] [Related]
31. DePEGylation strategies to increase cancer nanomedicine efficacy.
Kong L; Campbell F; Kros A
Nanoscale Horiz; 2019 Mar; 4(2):378-387. PubMed ID: 32254090
[TBL] [Abstract][Full Text] [Related]
32. Cancer nanomedicines: so many papers and so few drugs!
Venditto VJ; Szoka FC
Adv Drug Deliv Rev; 2013 Jan; 65(1):80-8. PubMed ID: 23036224
[TBL] [Abstract][Full Text] [Related]
33. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine.
Pearce AK; O'Reilly RK
Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642
[TBL] [Abstract][Full Text] [Related]
34. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
Gupta M; Agrawal GP; Vyas SP
Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
[TBL] [Abstract][Full Text] [Related]
35. Cancer nanomedicine: a review of recent success in drug delivery.
Tran S; DeGiovanni PJ; Piel B; Rai P
Clin Transl Med; 2017 Dec; 6(1):44. PubMed ID: 29230567
[TBL] [Abstract][Full Text] [Related]
36. Enhancing Tumor Penetration of Nanomedicines.
Sun Q; Ojha T; Kiessling F; Lammers T; Shi Y
Biomacromolecules; 2017 May; 18(5):1449-1459. PubMed ID: 28328191
[TBL] [Abstract][Full Text] [Related]
37. Current understandings and clinical translation of nanomedicines for breast cancer therapy.
Jiang Y; Jiang Z; Wang M; Ma L
Adv Drug Deliv Rev; 2022 Jan; 180():114034. PubMed ID: 34736986
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of nanomedicines for prostate cancer: An update.
Lakshmanan VK
Investig Clin Urol; 2016 Jan; 57(1):21-9. PubMed ID: 26966723
[TBL] [Abstract][Full Text] [Related]
39. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers.
Yang J; Wang X; Wang B; Park K; Wooley K; Zhang S
Adv Drug Deliv Rev; 2022 Nov; 190():114525. PubMed ID: 36100142
[TBL] [Abstract][Full Text] [Related]
40. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
Muthu MS; Singh S
Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
